Ardelyx to Participate in Upcoming Investor Conferences

Company Participation in Investor Conferences - Ardelyx, Inc. will participate in the Leerink Partners 2025 Global Healthcare Conference on March 11, 2025, at 8:00 a.m. ET, with 1x1 meetings scheduled for the same day [1] - The company will also attend the Jefferies Biotech on the Beach Summit on March 12, 2025, with 1x1 meetings planned [2] - Additionally, Ardelyx will be part of the Barclays 27th Annual Global Healthcare Conference on March 13, 2025, featuring a fireside chat at 10:00 a.m. ET and 1x1 meetings [2] Company Overview - Ardelyx, Inc. is focused on discovering, developing, and commercializing innovative, first-in-class medicines to address significant unmet medical needs [3] - The company has two commercial products approved in the United States: IBSRELA (tenapanor) and XPHOZAH (tenapanor) [3] - Ardelyx has international agreements for the development and commercialization of tenapanor, including partnerships with Kyowa Kirin in Japan and Fosun Pharma in China [3]